DATAFLOW,REF_AREA:Geographic area,INDICATOR:Indicator,SEX:Sex,TIME_PERIOD:Time period,OBS_VALUE:Observation Value,UNIT_MULTIPLIER:Unit multiplier,UNIT_MEASURE:Unit of measure,OBS_STATUS:Observation Status,OBS_CONF:Observation confidentaility,LOWER_BOUND:Lower Bound,UPPER_BOUND:Upper Bound,WGTD_SAMPL_SIZE:Weighted Sample Size,OBS_FOOTNOTE:Observation footnote,SERIES_FOOTNOTE:Series footnote,DATA_SOURCE:Data Source,SOURCE_LINK:Citation of or link to the data source,CUSTODIAN:Custodian,TIME_PERIOD_METHOD:Time period activity related to when the data are collected,REF_PERIOD:Reference Period,COVERAGE_TIME:The period of time for which data are provided,AGE:Current age
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,39,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,30,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AFG: Afghanistan,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,25,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,4,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,32,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AFRO: Africa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ALB: Albania,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DZA: Algeria,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_AMRO: Americas,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AND: Andorra,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,40,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AGO: Angola,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ATG: Antigua and Barbuda,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,7,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARG: Argentina,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARM: Armenia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUS: Australia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AUT: Austria,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,61,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,AZE: Azerbaijan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHS: Bahamas,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BHR: Bahrain,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGD: Bangladesh,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRB: Barbados,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLR: Belarus,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEL: Belgium,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BLZ: Belize,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BEN: Benin,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BTN: Bhutan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BOL: Bolivia (Plurinational State of),"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,38,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BIH: Bosnia and Herzegovina,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BWA: Botswana,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRA: Brazil,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BRN: Brunei Darussalam,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BGR: Bulgaria,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,31,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BFA: Burkina Faso,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,BDI: Burundi,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CPV: Cabo Verde,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KHM: Cambodia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CMR: Cameroon,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAN: Canada,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,49,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CAF: Central African Republic,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,61,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,41,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,29,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TCD: Chad,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHL: Chile,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHN: China,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COL: Colombia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COM: Comoros,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COG: Congo,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COK: Cook Islands,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CRI: Costa Rica,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HRV: Croatia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CUB: Cuba,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CYP: Cyprus,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CZE: Czechia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CIV: Côte d'Ivoire,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRK: Democratic People's Republic of Korea,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,COD: Democratic Republic of the Congo,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DNK: Denmark,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DJI: Djibouti,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,44,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DMA: Dominica,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DOM: Dominican Republic,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,31,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,13,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,1,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EAP: East Asia and Pacific,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,16,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_EECA: Eastern Europe and Central Asia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,34,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,51,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EMRO: Eastern Mediterranean,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,6,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,38,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,40,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ESA: Eastern and Southern Africa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ECU: Ecuador,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EGY: Egypt,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLV: El Salvador,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNQ: Equatorial Guinea,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,29,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ERI: Eritrea,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,EST: Estonia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWZ: Eswatini,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ETH: Ethiopia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,52,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,40,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,25,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_EURO: Europe,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,39,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,24,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_ECA: Europe and Central Asia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FJI: Fiji,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FIN: Finland,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FRA: France,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GAB: Gabon,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,61,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GMB: Gambia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GEO: Georgia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,DEU: Germany,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GHA: Ghana,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRC: Greece,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,20,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GRD: Grenada,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GTM: Guatemala,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,40,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GIN: Guinea,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,3,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GNB: Guinea-Bissau,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GUY: Guyana,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,38,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HTI: Haiti,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,1,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HND: Honduras,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,HUN: Hungary,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISL: Iceland,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IND: India,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,6,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IDN: Indonesia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,40,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRN: Iran (Islamic Republic of),IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,43,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,41,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRQ: Iraq,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,32,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,IRL: Ireland,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ISR: Israel,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ITA: Italy,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,19,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JAM: Jamaica,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JPN: Japan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,JOR: Jordan,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KAZ: Kazakhstan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,1,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KEN: Kenya,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KIR: Kiribati,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KWT: Kuwait,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KGZ: Kyrgyzstan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LAO: Lao People's Democratic Republic,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,57,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_LAC: Latin America and Caribbean,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LVA: Latvia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBN: Lebanon,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,39,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LSO: Lesotho,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBR: Liberia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LBY: Libya,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LTU: Lithuania,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,1,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LUX: Luxembourg,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDG: Madagascar,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MWI: Malawi,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MYS: Malaysia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDV: Maldives,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLI: Mali,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MLT: Malta,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,61,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MHL: Marshall Islands,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MRT: Mauritania,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MUS: Mauritius,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MEX: Mexico,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,FSM: Micronesia (Federated States of),IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,52,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,38,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,32,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_MENA: Middle East and North Africa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MCO: Monaco,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNG: Mongolia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,26,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MNE: Montenegro,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,36,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MAR: Morocco,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MOZ: Mozambique,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MMR: Myanmar,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,7,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,61,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NAM: Namibia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NRU: Nauru,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,16,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NPL: Nepal,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NLD: Netherlands,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NZL: New Zealand,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIC: Nicaragua,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NER: Niger,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NGA: Nigeria,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NIU: Niue,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_NA: North America,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MKD: North Macedonia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,NOR: Norway,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,OMN: Oman,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAK: Pakistan,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PLW: Palau,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,6,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PAN: Panama,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,52,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,44,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,37,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,25,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,37,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PNG: Papua New Guinea,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRY: Paraguay,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PER: Peru,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,40,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,43,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PHL: Philippines,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,41,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,POL: Poland,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PRT: Portugal,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,QAT: Qatar,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KOR: Republic of Korea,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,MDA: Republic of Moldova,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ROU: Romania,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RUS: Russian Federation,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,RWA: Rwanda,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,KNA: Saint Kitts and Nevis,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LCA: Saint Lucia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,17,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VCT: Saint Vincent and the Grenadines,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,34,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,31,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,31,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,34,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,13,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,31,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,34,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WSM: Samoa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SMR: San Marino,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,STP: Sao Tome and Principe,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SAU: Saudi Arabia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SEN: Senegal,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SRB: Serbia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYC: Seychelles,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,16,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLE: Sierra Leone,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SGP: Singapore,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVK: Slovakia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SVN: Slovenia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SLB: Solomon Islands,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,37,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,52,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SOM: Somalia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,42,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,70,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZAF: South Africa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,38,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,28,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SA: South Asia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,52,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,51,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,49,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,49,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,50,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,49,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,49,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SSD: South Sudan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,39,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,49,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,16,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_SEARO: Southeast Asia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,24,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ESP: Spain,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,LKA: Sri Lanka,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,PSE: State of Palestine,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SDN: Sudan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SUR: Suriname,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,26,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SWE: Sweden,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,CHE: Switzerland,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,47,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,SYR: Syrian Arab Republic,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TJK: Tajikistan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,51,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,THA: Thailand,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,54,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TLS: Timor-Leste,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,77,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,20,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TGO: Togo,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TON: Tonga,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TTO: Trinidad and Tobago,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUN: Tunisia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUR: Turkey,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TKM: Turkmenistan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,81,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TUV: Tuvalu,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,41,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,34,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_REP_REG_GLOBAL: UNICEF reporting regions - Global,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UGA: Uganda,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,36,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,87,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,67,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UKR: Ukraine,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ARE: United Arab Emirates,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,GBR: United Kingdom,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,82,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,TZA: United Republic of Tanzania,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,USA: United States,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,URY: Uruguay,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,99,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UZB: Uzbekistan,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,56,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VUT: Vanuatu,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,92,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,53,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,55,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,60,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,39,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VEN: Venezuela (Bolivarian Republic of),IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,32,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,97,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,VNM: Viet Nam,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,19,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,76,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,74,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,63,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,61,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,66,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,62,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,12,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,27,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,18,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,58,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WCA: West and Central Africa,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,2,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,98,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,9,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,84,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_WE: Western Europe,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,35,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,96,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,93,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,23,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,13,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,1,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_WPRO: Western Pacific,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,86,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,85,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,83,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,71,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,45,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,41,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,34,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,WHO_REG_GLOBAL: World Health Organisation regions - Global,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,75,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,46,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,YEM: Yemen,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,64,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,65,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,91,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZMB: Zambia,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,36,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,95,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,94,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,89,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,90,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,78,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,ZWE: Zimbabwe,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,88,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_BCG: Percentage of live births who received bacille Calmette-Guerin (vaccine against tuberculosis),_T: Total,2018,79,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_DTP1: Percentage of surviving infants who received the first dose of DTP-containing vaccine,_T: Total,2018,80,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_DTP3: Percentage of surviving infants who received the third dose of DTP-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_MCV1: Percentage of surviving infants who received the first dose of measles-containing vaccine,_T: Total,2018,69,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_POL3: Percentage of surviving infants who received the third dose of inactivated polio-containing vaccine,_T: Total,2018,72,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_HEPB3: Percentage of surviving infants who received the third dose of hep B-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_YFV: Percentage of surviving infants who received yellow fever- containing vaccine (for countries at risk and where the vaccine is in the national schedule),_T: Total,2018,43,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_HIB3: Percentage of surviving infants who received the third dose of Hib-containing vaccine,_T: Total,2018,73,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,"IM_MCV2: Percentage of children who received the 2nd dose of measles-containing vaccine, as per administered in the national schedule",_T: Total,2018,25,0: Units,PCNT: %,E: Estimated value,F: Free,,,,"Generally, the second dose of measles-containing vaccine (MCV2) is recommended for administration during the second year of life; however, in many countries, MCV2 is scheduled after the second year.",,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,_T: Total
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_ROTAC: Percentage of surviving infants who received the last dose of rotavirus-containing vaccine (2nd or 3rd dose depending on vaccine used),_T: Total,2018,48,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_PCV3: Percentage of surviving infants who received the third dose of pneumococcal conjugate-containing vaccine (PCV),_T: Total,2018,68,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_RCV1: Percentage of surviving infants who received the first dose of rubella-containing vaccine,_T: Total,2018,29,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_IPV1: Percentage of surviving infants who received the first dose of inactivated polio-containing vaccine,_T: Total,2018,59,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,M12T23: 12 to 23 months old
UNICEF:GLOBAL_DATAFLOW(1.0): Cross-sector indicators,UNICEF_SSA: sub-Saharan Africa,IM_HEPBB: Percentage of live births who received hepatitis-B-containing vaccine within 24 hours of birth,_T: Total,2018,1,0: Units,PCNT: %,E: Estimated value,F: Free,,,,,,"WHO/UNICEF estimates of national immunization coverage, 2019 revision",,,,,,Y0: Under 1 year old
